糖胺聚糖
硫酸化
细胞生物学
化学
蛋白多糖
硫酸软骨素
硫酸皮肤素
生物化学
巨噬细胞极化
比格里坎
软骨素
巨噬细胞
细胞
生物
细胞外基质
多糖
体外
作者
Pierre Martinez,A Denys,Maxime Delos,Anne‐Sophie Sikora,Mathieu Carpentier,Sylvain Julien,Joël Pestel,Fabrice Allain
出处
期刊:Glycobiology
[Oxford University Press]
日期:2014-12-11
卷期号:25 (5): 502-513
被引量:60
标识
DOI:10.1093/glycob/cwu137
摘要
Macrophages are major cells of inflammatory process and take part in a large number of physiological and pathological processes. According to tissue environment, they can polarize into pro-inflammatory (M1) or alternative (M2) cells. Although many evidences have hinted to a potential role of cell-surface glycosaminoglycans (GAGs) in the functions of macrophages, the effect of M1 or M2 polarization on the biosynthesis of these polysaccharides has not been investigated so far. GAGs are composed of repeat sulfated disaccharide units. Heparan (HS) and chondroitin/dermatan sulfates (CS/DS) are the major GAGs expressed at the cell membrane. They are involved in numerous biological processes, which rely on their ability to selectively interact with a large panel of proteins. More than 20 genes encoding sulfotransferases have been implicated in HS and CS/DS biosynthesis, and the functional repertoire of HS and CS/DS has been related to the expression of these isoenzymes. In this study, we analyzed the expression of sulfotransferases as a response to macrophage polarization. We found that M1 and M2 activation drastically modified the profiles of expression of numerous HS and CS/DS sulfotransferases. This was accompanied by the expression of GAGs with distinct structural features. We then demonstrated that GAGs of M2 macrophages were efficient to present fibroblast growth factor-2 in an assay of tumor cell proliferation, thus indicating that changes in GAG structure may contribute to the functions of polarized macrophages. Altogether, our findings suggest a regulatory mechanism in which fine modifications in GAG biosynthesis may participate to the plasticity of macrophage functions.
科研通智能强力驱动
Strongly Powered by AbleSci AI